Cargando…
Potential Benefits of Pre-emptive PGx Testing in Male Breast Cancer Patients
The objective is to report a case of recurrent breast cancer in a poor CYP2D6 metabolizer male patient on tamoxifen, and how pharmacogenomic (PGx) testing can play an important role in selecting appropriate adjuvant endocrine therapy. The case examined here is a 60-year-old white male diagnosed with...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
University of Minnesota Libraries Publishing
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8051901/ https://www.ncbi.nlm.nih.gov/pubmed/34007593 http://dx.doi.org/10.24926/iip.v10i4.2303 |